Booker winner George Saunders coming to Vancouver in February
Booker Prize-winning author George Saunders will discuss his new novel 'Vigil' at a Vancouver Writers Fest event on February 6. Get tickets now for this literary highlight.
Category : Search result: novel therapeutics
J&J buys Halda Therapeutics for $3.05 billion
Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.
Baseball League Launches in Dubai with Camels and New Rules
The Baseball United league has launched its inaugural season in Dubai, featuring innovative rules and a unique desert setting. Discover how this new professional sports venture is changing the game.
Adele's Acting Debut in Tom Ford's 'Cry to Heaven'
Global superstar Adele is set to make her acting debut in Tom Ford's adaptation of 'Cry to Heaven.' The announcement marks a major career move for the Grammy-winning artist. Read more about this exciting Hollywood development.
Montreal-born David Szalay wins Booker Prize
Montreal-born author David Szalay has won the prestigious 2025 Booker Prize for his novel 'Flesh'. The award was presented at a ceremony in London on November 10, 2025.
Boehringer Ingelheim Licenses Novel Autoimmune Treatment
Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.
Sudbury Author's AI Dystopia: Humanity's Last Stand
Sudbury author explores a terrifying future dominated by artificial intelligence in his new speculative fiction novel that questions our technological trajectory.
Page 1 of 1